We are live on ! Find out more
PCM

Portolan Capital Management Portfolio holdings

AUM $2.67B
1-Year Est. Return 169.09%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+169.09%
3 Year Est. Return
+737.83%
5 Year Est. Return
+1,497.12%
10 Year Est. Return
+21,256.61%
AUM
$1.21B
AUM Growth
-$98.5M
Cap. Flow
-$79M
Cap. Flow %
-6.5%
Top 10 Hldgs %
27.39%
Holding
137
New
21
Increased
36
Reduced
59
Closed
20

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$12.6M
2
PHAT icon
Phathom Pharmaceuticals
PHAT
+$11.6M
3
TTMI icon
TTM Technologies
TTMI
+$11.5M
4
ORN icon
Orion Group Holdings
ORN
+$11.2M
5
MRVI icon
Maravai LifeSciences
MRVI
+$10.1M

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$19.2M
2
WKME
WalkMe Ltd. Ordinary Shares
WKME
+$19.1M
3
SG icon
Sweetgreen
SG
+$15.8M
4
UTHR icon
United Therapeutics
UTHR
+$14.8M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$14.1M

Sector Composition

Rank Sector Weight
1 Technology 33.79%
2 Healthcare 21.3%
3 Industrials 12.49%
4 Consumer Discretionary 8.15%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BELFB
101
Bel Fuse Inc Class B
BELFB
$3.58B
$3.54M 0.29%
54,237
-53,460
-50% -$3.36M
GENK icon
102
GEN Restaurant Group
GENK
$10.1M
$3.32M 0.27%
366,118
+456
+0.1% +$4.79K
SKY icon
103
Champion Homes
SKY
$4.59B
$3.01M 0.25%
44,426
-36,221
-45% -$2.71M
DIBS icon
104
1stdibs.com
DIBS
$159M
$2.97M 0.24%
660,953
+6,276
+1% +$34.3K
EVER icon
105
EverQuote
EVER
$879M
$2.93M 0.24%
140,232
-227,009
-62% -$4.8M
MSFT icon
106
Microsoft
MSFT
$3.67T
$2.37M 0.2%
5,300
-2
-0% -$845
OPK icon
107
Opko Health
OPK
$1.19B
$2.36M 0.19%
1,886,749
-1,354,669
-42% -$1.76M
MAMA icon
108
Mama's Creations
MAMA
$731M
$2.32M 0.19%
+344,024
New +$2.1M
WEX icon
109
WEX
WEX
$6.38B
$2.28M 0.19%
+12,863
New +$2.62M
RELY icon
110
Remitly
RELY
$5.26B
$2.18M 0.18%
179,892
+4,065
+2% +$63K
SMTC icon
111
Semtech
SMTC
$15.2B
$1.92M 0.16%
64,182
-101,735
-61% -$3.56M
CWST icon
112
Casella Waste Systems
CWST
$5.86B
$1.56M 0.13%
15,682
-9
-0.1% -$867
GOOG icon
113
Alphabet (Google) Class C
GOOG
$4.1T
$1.13M 0.09%
6,171
-1
-0% -$170
ICAD
114
DELISTED
iCAD Inc
ICAD
$849K 0.07%
653,372
-554,894
-46% -$854K
BXC icon
115
BlueLinx
BXC
$638M
$394K 0.03%
4,229
– –
NRDY icon
116
Nerdy
NRDY
$76.2M
$53.6K ﹤0.01%
2,140
-192,671
-99% -$6.35M
HBIO icon
117
Harvard Bioscience
HBIO
$36.2M
$34.2K ﹤0.01%
1,200
-68,584
-98% -$2.41M
ALRM icon
118
Alarm.com
ALRM
$2.75B
– –
-50,201
Closed -$3.64M
AXTI icon
119
AXT Inc
AXTI
$4.56B
– –
-1,596,232
Closed -$7.33M
AZZ icon
120
AZZ Inc
AZZ
$4.19B
– –
-51,323
Closed -$3.97M
CYRX icon
121
CryoPort
CYRX
$784M
– –
-295,652
Closed -$5.23M
DOCN icon
122
DigitalOcean
DOCN
$14.9B
– –
-132,137
Closed -$5.04M
DOUG icon
123
Douglas Elliman
DOUG
$162M
– –
-2,215,469
Closed -$3.5M
GDS icon
124
GDS Holdings
GDS
$6.41B
– –
-1,663,662
Closed -$11.1M
GFL icon
125
GFL Environmental
GFL
$18.7B
– –
-189,386
Closed -$6.53M
2 3 4
5
6

Similar funds

IAS
Insigneo Advisory Services Miami, Florida $2.67B AUM 40.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
BWFA
Baltimore-Washington Financial Advisors Columbia, Maryland $2.67B AUM 19.65% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
UPS
UHLMANN PRICE SECURITIES Skokie, Illinois $2.68B AUM 149.5% 1-Year Est. Return

Portolan Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Portolan Capital Management held 137 positions worth $1.21B, down 7.5% from $1.31B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Portolan Capital Management withdrew a net $79M in Q2 2024, closing 20 positions and reducing 59 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Portolan Capital Management opened a new position in Phathom Pharmaceuticals worth $11.6M.

  • Portolan Capital Management's largest Q2 2024 buy was Phathom Pharmaceuticals: 1,130,089 shares worth $11.6M.
  • Portolan Capital Management added most to Quanterix in Q2 2024, an estimated $12.6M increase.
  • Portolan Capital Management's biggest Q2 2024 reduction was Bio-Rad Laboratories Class A, cutting an estimated $19.2M.
  • Portolan Capital Management fully exited R1 RCM Inc. Common Stock in Q2 2024, selling an estimated $14.1M.
  • Portolan Capital Management's ten largest holdings make up 27% of its $1.21B portfolio in Q2 2024.
  • Portolan Capital Management opened 21 new positions and closed 20 in Q2 2024.
  • Portolan Capital Management's portfolio value fell 7.5% quarter-over-quarter to $1.21B.

Based on Portolan Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.